Research is being conducted on oligonucleotides, with various companies contributing to their development as therapeutic agents. The field is exploring different aspects, including delivery methods, manufacturing approaches, and potential applications in treating diseases. Oligonucleotides are being studied for their potential as next-generation medicines, with multiple companies involved in their development and clinical trials.